SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-072832
Filing Date
2023-08-31
Accepted
2023-08-31 16:10:56
Documents
95
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184362-6k_universe.htm   iXBRL 6-K 31666
2 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AND RELATED NOTES AS OF MARCH 31, 20 ea184362ex99-1_universe.htm   iXBRL EX-99.1 536246
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea184362ex99-2_universe.htm EX-99.2 257804
  Complete submission text file 0001213900-23-072832.txt   5587621

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE upc-20230331.xsd EX-101.SCH 86357
5 XBRL CALCULATION FILE upc-20230331_cal.xml EX-101.CAL 34213
6 XBRL DEFINITION FILE upc-20230331_def.xml EX-101.DEF 307691
7 XBRL LABEL FILE upc-20230331_lab.xml EX-101.LAB 540011
8 XBRL PRESENTATION FILE upc-20230331_pre.xml EX-101.PRE 317536
89 EXTRACTED XBRL INSTANCE DOCUMENT ea184362-6k_universe_htm.xml XML 594631
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 231229135
SIC: 2834 Pharmaceutical Preparations